The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer.

STUDY OBJECTIVES It is known that chromium is one of the important inhaled carcinogens that cause lung cancer. Our previous studies revealed a variety of genetic changes in lung cancers from chromate-exposed workers (chromate lung cancer). However, the epigenetic effects of chromium are not understood. MATERIALS AND METHODS We investigated the methylation of the p16 gene using a methylation-specific PCR method in 30 chromate lung cancers and 38 non-chromate lung cancers, and the expression of the p16 protein using immunohistochemistry in 25 chromate lung cancers. RESULTS Ten (33%) chromate lung cancers showed methylation of the p16 promoter region. On the other hand, 10 (26%) of the non-chromate lung cancers also showed it. The frequency of p16 methylation in non-chromate lung cancer was 0%, 33% and 30% for low (< or =600), moderate (<600, >1000) and high (> or =1000) Brinkman indexes, respectively. However, the frequency of p16 methylation in chromate lung cancer was constant, irrespective of the Brinkman index. In chromate lung cancer, patients with chromate exposure of less than 15 years never had p16 methylation, while 40% (> or =25 years) or 43% (> or =15, <25 years) of patients with chromate exposure of more than 15 years did. In chromate lung cancer, chromate exposure, not smoking, mainly influenced the p16 methylation. Most of the chromate lung cancers with p16 methylation (85.7%) showed repression of the p16 protein. CONCLUSIONS We speculate that not only genetic but also epigenetic alterations are involved in the carcinogenesis due to chromium.

[1]  K. Kondo,et al.  Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers. , 2001, American journal of industrial medicine.

[2]  L. Thiberville,et al.  Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: A prospective study in high‐risk patients without invasive cancer. , 2002, International journal of cancer.

[3]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[4]  J. Herman,et al.  Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer , 1999, Oncogene.

[5]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[6]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[7]  Y. Shimosato,et al.  Histological Typing of Lung Tumours 1 , 1981 .

[8]  A. Ochiai,et al.  Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate‐exposed workers , 2005, Molecular carcinogenesis.

[9]  T. Mok,et al.  Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer , 2002, Journal of surgical oncology.

[10]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  John K. Wiencke,et al.  p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer , 2001 .

[12]  D. Niewoehner,et al.  Rb and p16INK4a expression in resected non-small cell lung tumors. , 1996, Cancer research.

[13]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Franklin,et al.  Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. , 1997, Cancer research.

[15]  Frank D Gilliland,et al.  Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. , 2004, Carcinogenesis.

[16]  K. Kondo,et al.  Frequent microsatellite instability in lung cancer from chromate‐exposed workers , 2002, Molecular carcinogenesis.

[17]  V. Gouyer,et al.  Mechanisms of p16INK4A inactivation in non small-cell lung cancers , 1998, Oncogene.

[18]  K. Kondo,et al.  Mutations of the p53 Gene in Human Lung Cancer from Chromate-Exposed Workers , 1997 .

[19]  S. Anttila,et al.  Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer , 2003, International journal of cancer.

[20]  J. Herman,et al.  Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. , 2001, Cancer research.

[21]  J. Herman,et al.  Frequent aberrant methylation of p16INK4a in primary rat lung tumors , 1997, Molecular and cellular biology.

[22]  S. Weitzman,et al.  Influence of oxygen radical injury on DNA methylation. , 1997, Mutation research.

[23]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[24]  J. Minna,et al.  Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer , 2003, International journal of cancer.

[25]  S. Patierno,et al.  Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. , 2003, Mutation research.

[26]  J. Arbiser,et al.  Reactive Oxygen-induced Carcinogenesis Causes Hypermethylation of p16Ink4a and Activation of MAP Kinase , 2002, Molecular medicine.

[27]  J. Minna,et al.  Aberrant promoter methylation of multiple genes in non-small cell lung cancers. , 2001, Cancer research.

[28]  S. Imazio,et al.  Genetic and DNA-methylation changes induced by potassium dichromate in Brassica napus L. , 2004, Chemosphere.

[29]  D. Casciato.  Manual of Clinical Oncology , 1995 .

[30]  J. Geradts,et al.  High frequency of aberrant p16(INK4A) expression in human breast cancer. , 1996, The American journal of pathology.

[31]  M. Ingelman-Sundberg,et al.  Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes. , 1991, Carcinogenesis.

[32]  J. Jen,et al.  Detailed deletion mapping at chromosome 9p21 in non‐small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization , 1997, International journal of cancer.

[33]  T. Motoyama,et al.  Frequent Epigenetic Silencing of the p16 Gene in Non‐small Cell Lung Cancers of Tobacco Smokers , 2002, Japanese journal of cancer research : Gann.